RECRO PHARMA INC's ticker is REPH and the CUSIP is 75629F109. A total of 75 filers reported holding RECRO PHARMA INC in Q1 2019. The put-call ratio across all filers is 1.75 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2020 | $298,000 | -44.2% | 65,397 | 0.0% | 0.07% | -61.0% |
| Q1 2020 | $534,000 | -43.8% | 65,397 | +26.2% | 0.19% | -11.8% |
| Q4 2019 | $950,000 | -2.8% | 51,802 | -41.2% | 0.21% | +44.2% |
| Q3 2019 | $977,000 | +23.7% | 88,137 | +13.5% | 0.15% | +30.1% |
| Q2 2019 | $790,000 | +104.7% | 77,687 | +17.9% | 0.11% | +94.8% |
| Q1 2019 | $386,000 | -2.8% | 65,917 | +18.0% | 0.06% | +1.8% |
| Q4 2018 | $397,000 | +57.5% | 55,857 | +57.4% | 0.06% | +147.8% |
| Q3 2018 | $252,000 | +41.6% | 35,490 | 0.0% | 0.02% | +43.8% |
| Q2 2018 | $178,000 | – | 35,490 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| MAK CAPITAL ONE LLC | 850,129 | $2,423,000 | 0.65% |
| Newtyn Management, LLC | 700,000 | $1,995,000 | 0.46% |
| Portolan Capital Management | 1,293,376 | $3,686,000 | 0.34% |
| Rubric Capital Management LP | 1,076,587 | $3,068,000 | 0.22% |
| ESSEX INVESTMENT MANAGEMENT CO LLC | 99,046 | $282,000 | 0.04% |
| Alyeska Investment Group, L.P. | 736,821 | $2,100,000 | 0.03% |
| STEPHENS INC /AR/ | 510,569 | $1,455,000 | 0.03% |
| Clear Harbor Asset Management, LLC | 46,682 | $133,000 | 0.02% |
| WYNNEFIELD CAPITAL INC | 13,000 | $37,000 | 0.02% |
| JACOBS LEVY EQUITY MANAGEMENT, INC | 451,301 | $1,286,000 | 0.01% |